Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Aharon Schwartz currently holds 7,500 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aharon Schwartz has been a net buyer of PLX stock. They have purchased $956.0K and sold $0 worth of shares.
Aharon Schwartz's most recent insider trade was on Sep 3, 2025, when they sold 7,500 shares at $0.00 per share.
Aharon Schwartz serves as Executive at Protalix BioTherapeutics, Inc. (PLX). They have executed 8 insider transactions totaling $956.0K over their tenure at the company.
Aharon Schwartz holds the position of Executive at Protalix BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Aharon Schwartz has shown a buying trading pattern, with $956.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Aharon Schwartz was on Jun 10, 2025, when they purchased $206.4K worth of PLX shares. This transaction involved 129,000 shares at $1.60 per share.
Aharon Schwartz currently owns 7,500 shares of Protalix BioTherapeutics, Inc. (PLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Aharon Schwartz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aharon Schwartz has 8 Form 4 filings on record as an insider at Protalix BioTherapeutics, Inc..
Set alerts for Aharon Schwartz and 40,000+ other insiders.